drugset / Trial / NCT02757755
Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults
Phase 1
Completed
12 enrolled
Armata Pharmaceuticals, Inc.
Walter Reed Army Institute of Research (WRAIR) · collab
RandomizedDouble-blind
Summary
This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AB-SA01 | Other / unclassified | 1e+08 unknown | Topical |
| Subject | AB-SA01 | Other / unclassified | 1e+09 unknown | Topical |
Indications
No indication recorded.